, Tracking Stock Market Picks
Enter Symbol:
Rating: RMD
Hold $50

Resmed Inc. (NYSE: RMD) reiterated to Hold with price target $50 by Canaccord Genuity

Friday,  Jan 23, 2015  12:25 PM ET by Betsy O'Brien Harrison

Canaccord Genuity reiterated Resmed Inc. (NYSE: RMD) to Hold with price target $50. Previously Canaccord Genuity reiterated
Resmed Inc. (NYSE: RMD) to Hold with price target $43 on 01/24/2014, when the stock price was $44.02. Since then, Resmed Inc.'s stock price has gained 52% as of 01/23/2015's recent price of $67.10.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy